Delving into the Latest Updates on Beijing Shijikang Pharmaceutical Technology Development Co., Ltd. with Synapse

Overview

The main purpose is to evaluate the effectiveness and safety of Qudu Zengning Capsule on the changes in viral load in HIV-infected patients after 24 weeks of treatment, and to explore the effect of Qudu Zengning Capsule on immune reconstruction in HIV-infected patients, and the changes in clinical symptoms and signs before and after treatment.

Start Date08 Jul 2013

Sponsor / Collaborator

Beijing Shijikang Pharmaceutical Technology Development Co., Ltd.

CTR20170760

/ SuspendedPhase 2

袪毒增宁胶囊抗艾滋病毒临床研究

[Translation] Clinical study on the anti-HIV effect of Qudu Zengning capsule

评价袪毒增宁胶囊治疗HIV/AIDS（气阴两虚兼内热证）有效性和安全性

[Translation]

To evaluate the effectiveness and safety of Qudu Zengning Capsule in the treatment of HIV/AIDS (Qi and Yin deficiency with internal heat syndrome)

Start Date-

Sponsor / Collaborator

Beijing Shijikang Pharmaceutical Technology Development Co., Ltd.

100 Clinical Results associated with Beijing Shijikang Pharmaceutical Technology Development Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Beijing Shijikang Pharmaceutical Technology Development Co., Ltd.

Login to view more data

100 Deals associated with Beijing Shijikang Pharmaceutical Technology Development Co., Ltd.

Login to view more data

100 Translational Medicine associated with Beijing Shijikang Pharmaceutical Technology Development Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Aug 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data